Vestal Point Capital, LP - 31 Dec 2024 SCHEDULE 13G Report for Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT)

Filing Manager: Vestal Point Capital, LP
Reporting Manager: Vestal Point Capital, LP
Security: Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: APLT
Shares outstanding: 116,161,616 shares
Disclosed Ownership: 11,500,000 shares
Ownership: 9.9%
Form type: SCHEDULE 13G
Filing time: 14 Feb 2025, 14:35:21 UTC
Date of event: 31 Dec 2024
Next filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vestal Point Capital, LP	9.9%	11,500,000	0	11,500,000	/s/ Ryan Wilder	By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Ryan Wilder	9.9%	11,500,000	0	11,500,000	/s/ Ryan Wilder	Ryan Wilder, Individually